Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385406293> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4385406293 endingPage "112" @default.
- W4385406293 startingPage "105" @default.
- W4385406293 abstract "Immunotherapy causes cancer patients' immune systems to activate in search of and eliminate cancer cells. As a therapeutic area for cancer, it has expanded in importance and demonstrated promising results in treating many cancers. Checkpoint blockade (CPB) therapy may stimulate a suppressed immune response to provide long-lasting therapeutic results. However, the absence of a tumor-reactive immune infiltration is probably why response rates are still low. Using chimeric antigen receptor (CAR)-modified T cells to fight cancer may significantly impact immunology. This study explored using checkpoint inhibitors, car-T cells, and vaccines in immunotherapy to treat cancers. Drugs used for CPB aim to reduce immunological suppression, allowing for more effective CAR T cells and dendritic cell (DC) vaccines, providing some optimism that this may be increased, both of which have proven therapeutic efficacy in specific cancers. However, drug-induced side effects and the tumor microenvironment's propensity for immunosuppression mean treatment effectiveness is still inadequate. The outcomes of current preclinical tests suggest that novel therapies targeting lymphocyte-activation gene 3 (LAG3), T cell immunoglobulin and mucin-domain containing-3 (TIM3), cytotoxic T lymphocyte-associated protein 4 (CTLA-4), and programmed cell death protein 1 (PD-1) could be used as adjuvant therapies to modify the tumor microenvironment." @default.
- W4385406293 created "2023-08-01" @default.
- W4385406293 creator A5000959667 @default.
- W4385406293 creator A5054908026 @default.
- W4385406293 creator A5083262668 @default.
- W4385406293 creator A5088337404 @default.
- W4385406293 creator A5092573082 @default.
- W4385406293 creator A5092573083 @default.
- W4385406293 date "2023-06-01" @default.
- W4385406293 modified "2023-09-25" @default.
- W4385406293 title "THE ROLE OF IMMUNOTHERAPY IN CANCER TREATMENT: CHECKPOINT INHIBITORS, CAR-T CELLS, AND VACCINES." @default.
- W4385406293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37522784" @default.
- W4385406293 hasPublicationYear "2023" @default.
- W4385406293 type Work @default.
- W4385406293 citedByCount "0" @default.
- W4385406293 crossrefType "journal-article" @default.
- W4385406293 hasAuthorship W4385406293A5000959667 @default.
- W4385406293 hasAuthorship W4385406293A5054908026 @default.
- W4385406293 hasAuthorship W4385406293A5083262668 @default.
- W4385406293 hasAuthorship W4385406293A5088337404 @default.
- W4385406293 hasAuthorship W4385406293A5092573082 @default.
- W4385406293 hasAuthorship W4385406293A5092573083 @default.
- W4385406293 hasConcept C121608353 @default.
- W4385406293 hasConcept C126322002 @default.
- W4385406293 hasConcept C154317977 @default.
- W4385406293 hasConcept C202751555 @default.
- W4385406293 hasConcept C203014093 @default.
- W4385406293 hasConcept C2776090121 @default.
- W4385406293 hasConcept C2776107976 @default.
- W4385406293 hasConcept C2777701055 @default.
- W4385406293 hasConcept C2777863537 @default.
- W4385406293 hasConcept C2778378633 @default.
- W4385406293 hasConcept C2780674031 @default.
- W4385406293 hasConcept C2780851360 @default.
- W4385406293 hasConcept C3875195 @default.
- W4385406293 hasConcept C502942594 @default.
- W4385406293 hasConcept C55493867 @default.
- W4385406293 hasConcept C71924100 @default.
- W4385406293 hasConcept C86803240 @default.
- W4385406293 hasConcept C8891405 @default.
- W4385406293 hasConceptScore W4385406293C121608353 @default.
- W4385406293 hasConceptScore W4385406293C126322002 @default.
- W4385406293 hasConceptScore W4385406293C154317977 @default.
- W4385406293 hasConceptScore W4385406293C202751555 @default.
- W4385406293 hasConceptScore W4385406293C203014093 @default.
- W4385406293 hasConceptScore W4385406293C2776090121 @default.
- W4385406293 hasConceptScore W4385406293C2776107976 @default.
- W4385406293 hasConceptScore W4385406293C2777701055 @default.
- W4385406293 hasConceptScore W4385406293C2777863537 @default.
- W4385406293 hasConceptScore W4385406293C2778378633 @default.
- W4385406293 hasConceptScore W4385406293C2780674031 @default.
- W4385406293 hasConceptScore W4385406293C2780851360 @default.
- W4385406293 hasConceptScore W4385406293C3875195 @default.
- W4385406293 hasConceptScore W4385406293C502942594 @default.
- W4385406293 hasConceptScore W4385406293C55493867 @default.
- W4385406293 hasConceptScore W4385406293C71924100 @default.
- W4385406293 hasConceptScore W4385406293C86803240 @default.
- W4385406293 hasConceptScore W4385406293C8891405 @default.
- W4385406293 hasIssue "339" @default.
- W4385406293 hasLocation W43854062931 @default.
- W4385406293 hasOpenAccess W4385406293 @default.
- W4385406293 hasPrimaryLocation W43854062931 @default.
- W4385406293 hasRelatedWork W3034810867 @default.
- W4385406293 hasRelatedWork W3041363051 @default.
- W4385406293 hasRelatedWork W3126740231 @default.
- W4385406293 hasRelatedWork W3134152892 @default.
- W4385406293 hasRelatedWork W3217412908 @default.
- W4385406293 hasRelatedWork W4281389645 @default.
- W4385406293 hasRelatedWork W4286629873 @default.
- W4385406293 hasRelatedWork W4296896234 @default.
- W4385406293 hasRelatedWork W4317934591 @default.
- W4385406293 hasRelatedWork W4360983034 @default.
- W4385406293 isParatext "false" @default.
- W4385406293 isRetracted "false" @default.
- W4385406293 workType "article" @default.